GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections ...

Adults with obesity may now move directly from Wegovy 2.4mg to 7.2mg if they need greater weight loss ...

The European Commission has granted final approval of a higher 7.2 mg maintenance dose of Wegovy® (semaglutide) for adults ...

Novo Nordisk NVO announced that the European Commission (EC) has approved a new 7.2 mg once-weekly maintenance dose of Wegovy (semaglutide injection) for adults with obesity. This provides physicians ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

The higher dosage was shown to help the average patient lose 21% of their body weight ...

A large, heavy Iftar meal is one of the main triggers. Dr Irshad advises that patients should eat slowly, consume smaller ...

FOR the first few months, Alisha Trafford’s Mounjaro journey was “magical”. The 25-year-old began taking the ‘King Kong’ of weight loss injections in February 2025, ordering the £135 jab from an ...

Michelle says she missed the red flag signs that the jab was fake ...

An India Today investigation into lax enforcement of drug norms that make accessing prescription-only medicines easy, and rising misuse of weight-loss drugs in the country.

The emergence of walk-in weight-loss injection services in the UK—where high-street pharmacies now offer “skinny jabs" like ...

Novo Nordisk A/S NVO plans to start selling its blockbuster obesity drug Wegovy in vials, marking its latest effort to ...